Since 2011 to present, Bernard B Singer is an associate professor at Institute of Anatomy, University Hospital, University Duisburg-Essen, in Germany. Since 2016 to present, he is Co-founder and CEO of LeukoCom Biotech, Essen, in Germany.
- he has also been a scientist, at Karolinska Institutet of Stockholm, in Sweden (1996 to 2000);
- he was a Scientific Director for antibody development at GenPat77 Biotech Company, in Berlin (2001 to 2002);
- Senior Scientist at the Institute for Biochemistry, Charite-Universitätsmedizin in Berlin (2003 to 2006 );
- Senior Scientist and lecturer at Institute of Anatomy, University Duisburg-Essen (2006 to 2011).
He is a DFG-funded immunologist/cell biologist/anatomist with a practice that focuses on the functional aspects of carcinoembryonic antigen-related cell adhesion molecules (CEACAMs).
He demonstrated the central role of CEACAM1 in orchestrating immune cell reactions an he generated a broad range of tools which made it easy and reliable to identify novel pathogens that specifically bind to CEACAMs.